Quorum Software, a global leader in energy software, today announced the acquisition of Streamba, an AI-native supply chain platform purpose-built for energy. This acquisition advances Quorum's position as the AI platform for the energy industry — embedding intelligent, real-time orchestration across upstream, midstream, measurement, SCADA and supply chain. For the first time, energy operators can connect planning, execution and back office in a single, AI-powered system. Quorum has built a c...

Toshiba Electronic Devices & Storage Corporation ("Toshiba") has expanded its lineup of digital isolators with DCL54xx01A series of quad-channel high-speed standard digital isolators for industrial equipment. The ten new products in the series are housed in an SOIC16-W package and deliver a maximum operating temperature of 125°C. Volume shipments start today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260527871751/en/Toshiba...

Bidgely is bringing its global insights tour to London from 10-12 June, marking the next vital stop in its premier EmPOWER AI conference series. Part of an international tour spanning Toronto and New York, the London forum serves as an active, collaborative hub for energy retailers ready to lead—rather than react to—rising electrification, critical load flexibility, next-generation customer experience and urgent energy affordability. This press release features multimedia. View the full releas...

Diabetology Limited (Jersey) poster presentation (https://diabetology.co.uk/ada-poster) 1724-P at the ADA 86th Scientific Session, New Orleans, reporting first human data from Oraglutide™ — small capsule intestinally-released oral semaglutide, formulated using the proprietary Axcess™ delivery technology. KEY HIGHLIGHTS 6-day glucose control: A single 4 mg oral dose of Oraglutide™ produced a sustained fall in glucose. Measuring 14% at Day 6 (p=.046), the longest duration presented from a si...

AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the appointment of Justyna Kelly as Chief Technology Officer (CTO) and François Gaudet as Chief Scientific Officer (CSO), expanding the company’s executive leadership team in the U.S. as it continues to scale its U.S. capabilities, and advance its growing pipeline of innovative targeted alpha therapies. Justyna Kelly will lead AdvanCell’s global technical operatio...

VENU+, a leading global provider of tech-enabled guest mobility, storage, and entertainment solutions and a portfolio company of Z Capital Group (“ZCG”), today announced a strategic partnership with Merlin Entertainments, a global leader in branded entertainment destinations, to enhance and expand photo capture experiences across Merlin’s international portfolio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260527425123/en/ The pa...

Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, today announced it has entered into a multi-aircraft fleet purchase agreement with Platoon Aviation that positions the Hamburg-based charter operator to become the largest Cessna Citation Longitude fleet owner in Europe. Platoon Aviation provides on-demand private jet travel, serving business and leisure travelers seeking long-range capability, cabin comfort and operational reliability. Deliveries of the Citation Longitude aircraft are e...

NIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced the launch of Survey Groups in NIQ Discover, a new capability that enables brands and retailers to understand not just what is changing in the market, but why. Available immediately within NIQ Discover, Survey Groups build on NIQ Panel Surveys by linking attitudinal insights to real-world purchase behavior from NIQ’s consumer panels—helping clients uncover the motivations behind performance shifts, identify opportunity...

The Access to Advanced Health Institute (AAHI), a nonprofit biotech organization dedicated to developing vaccines and technologies for global health, today congratulates Eli Lilly and Company and Curevo Vaccine on Lilly’s acquisition of Curevo. Curevo’s lead asset, amezosvatein (CRV-101), is a Phase 3-ready subunit vaccine for the prevention of shingles (herpes zoster) that incorporates AAHI’s proprietary SLA-SE adjuvant. The acquisition underscores the growing recognition of next-generation ...